Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lexicon Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXRX.
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Abeona Therapeutics (NASDAQ:ABEO), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).
Lexicon Pharmaceuticals has a consensus price target of $4.50.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $0.705 last updated April 25, 2025 at 7:56 PM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.